<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82715">
  <stage>Registered</stage>
  <submitdate>3/04/2008</submitdate>
  <approvaldate>11/04/2008</approvaldate>
  <actrnumber>ACTRN12608000187347</actrnumber>
  <trial_identification>
    <studytitle>Survival of bacteria on the ocular surface following double application of povidone-iodine before cataract surgery</studytitle>
    <scientifictitle>Survival of bacteria on the ocular surface following double application of povidone-iodine before cataract surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endophthalmitis</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Two applications of 5% povidone-iodine to the eye and surrounding skin prior to phacoemulsification cataract surgery. All patients will receive 5mL of povidone-iodine 5% solution applied via sterile swab and forceps to the conjunctival sac, lashes and periocular skin of the operative eye at time of the periorbital anaesthetic block as well as in theatre approximately 15 minutes later. Note: This is part of the standard procedure for the surgery, and NOT a new intervention.</interventions>
    <comparator>No control group - all patients receive 2 applications of povidone-iodine.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Bacterial recontamination of the conjunctiva following the first application of povidone iodine. This will be assessed by comparing cultures of swabs taken after the first application of povidone-iodine, with cultures of swabs taken just prior to the second application of povidone-iodine (about 15 minutes later). Bacterial recontamination could occur during this time. Each swab specimen will be put in a 1mL container of normal saline, from which 300 microlitres (100 microlitres, 3 times separately) is removed by automatic pipette and plated on blood agar (2 plates) as well as chocolate agar (1 plate). Each plate has 100 microlitres of broth applied to it. These plates will be sent for incubation within three hours of specimen collection. Specimens plated on blood agar will be incubated at 35 degrees centigrade a) aerobically, and b) anaerobically. The specimen on chocolate agar will be incubated at 35 degrees centigrade in 5% CO2.</outcome>
      <timepoint>Cultures assessed at three days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>No bacterial contamination following the first application of povidone-iodine. Swabs are cultured and assessed as in primary outcome.</outcome>
      <timepoint>Cultures assessed at three days</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Unilateral phacoemulsification surgery for cataract</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergy to povidone-iodine, active ocular infection, antibiotic therapy in preceding three weeks</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>28/04/2008</anticipatedstartdate>
    <actualstartdate>28/04/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate>23/05/2008</actualenddate>
    <samplesize>72</samplesize>
    <actualsamplesize>54</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>26/05/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <hospital>The Queen Elizabeth Hospital - Woodville</hospital>
    <hospital>Stirling District Hospital - Stirling</hospital>
    <postcode>5011 - Woodville</postcode>
    <postcode>5152 - Stirling</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Queen Elizabeth Hospital</primarysponsorname>
    <primarysponsoraddress>28 Woodville Rd, Woodville South, SA 5011</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>The Queen Elizabeth Hospital</fundingname>
      <fundingaddress>28 Woodville Rd, Woodville South, SA 5011</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To assess the incidence of positive preoperative conjunctival cultures with two (at time of periorbital anaesthetic block and in theatre approximately 15 minutes later) in comparison with one (at time of the anaesthetic block only) applications of 5% povidone-iodine solution to the operative eye before phacoemulsification cataract surgery.
	
Ultimately to assess whether microbial recontamination occurs after the initial application of povidone-iodine, and thus whether two applications of povidone-iodine are necessary in order to reduce the rate of positive preoperative conjunctival cultures.</summary>
    <trialwebsite />
    <publication>Stranz C, Fraenkel G, Butcher A, Esterman A, Goggin M. Survival of bacteria on the ocular surface following double application of povidone-iodine before cataract surgery. Eye (Lond) 2011; 25 (11): 1423-1428. </publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics of Human Research Committee (TQEH)</ethicname>
      <ethicaddress>28 Woodville Rd, Woodville South, SA 5011</ethicaddress>
      <ethicapprovaldate>14/04/2008</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>7/04/2008</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Conrad Stranz</name>
      <address>c/o
East Adelaide Medical Centre
50 Hutt Street
Adelaide SA 5000</address>
      <phone>+61 8 8210 9488</phone>
      <fax />
      <email>conrad.stranz@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Conrad Stranz</name>
      <address>c/o
East Adelaide Medical Centre
50 Hutt Street
Adelaide SA 5000</address>
      <phone>+61 8 8210 9488</phone>
      <fax />
      <email>conrad.stranz@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Conrad Stranz</name>
      <address>c/o
East Adelaide Medical Centre
50 Hutt Street
Adelaide SA 5000</address>
      <phone>+61 8 8210 9488</phone>
      <fax />
      <email>conrad.stranz@gmail.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Conrad Stranz</name>
      <address>c/o
East Adelaide Medical Centre
50 Hutt Street
Adelaide SA 5000</address>
      <phone>+61 8 8210 9488</phone>
      <fax />
      <email>conrad.stranz@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>